Process for the synthesis of 5- (methyl-1H-imidazol-1-yl) -3- (tri fluorome th yl) -benzeneamine

Details for Australian Patent Application No. 2006258051 (hide)

Owner Novartis AG

Inventors Shieh, Wen-Chung; McKenna, Joseph

Agent Davies Collison Cave

Pub. Number AU-B-2006258051

PCT Pub. Number WO2006/135641

Priority 60/688,977 09.06.05 US; 60/705,590 04.08.05 US

Filing date 7 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 9 September 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135641 Priority application(s): WO2006/135641

9 September 2010 Application Accepted

  Published as AU-B-2006258051

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258052-Medical stapler

2006258050-Process for the synthesis of organic compounds